By promoting cardiac hypertrophy and remodeling, resistin contributes to reducing cardiac output, which, in turn, exacerbates low cerebral blood flow and increases the likelihood of adverse outcomes post-stroke [44]. The gene discussed is RETN; the disease is stroke disorder.